Skip to main content
. 2021 Jun 16;10(13):e021084. doi: 10.1161/JAHA.121.021084

Figure 3. Use of GLP‐1RAs (glucagon like peptide‐1 receptor agonists) among patients with type 2 diabetes mellitus with guideline indications (A) and without guideline indications (B).

Figure 3

Error bars represent upper and lower limits of 95% CI for weighted percentage.